These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 2494154

  • 1. The scope and use of valproate in epilepsy.
    Penry JK, Dean JC.
    J Clin Psychiatry; 1989 Mar; 50 Suppl():17-22. PubMed ID: 2494154
    [Abstract] [Full Text] [Related]

  • 2. Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy.
    Davis R, Peters DH, McTavish D.
    Drugs; 1994 Feb; 47(2):332-72. PubMed ID: 7512905
    [Abstract] [Full Text] [Related]

  • 3. Valproate sodium in epilepsy. A clinical trial including monitoring of drug levels.
    Mehrotra TN, Aneja GK, Arora V, Goel S, Singh VS.
    J Assoc Physicians India; 1990 Apr; 38(4):277-9. PubMed ID: 2118134
    [Abstract] [Full Text] [Related]

  • 4. Divalproex and epilepsy.
    Willmore LJ.
    Psychopharmacol Bull; 2003 Apr; 37 Suppl 2():43-53. PubMed ID: 15021860
    [Abstract] [Full Text] [Related]

  • 5. Valproate in the treatment of epilepsy in people with intellectual disability.
    Friis ML.
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():32-5. PubMed ID: 10030429
    [Abstract] [Full Text] [Related]

  • 6. [Monotherapy with sodium valproate in generalized primary epilepsy. 2d phase: Study of long-term efficacy and tolerance].
    Feuerstein J, Revol M, Roger J, Sallou C, Truelle JL, Vercelletto P, Weber M.
    Sem Hop; 1983 Apr 21; 59(16):1263-74. PubMed ID: 6191393
    [Abstract] [Full Text] [Related]

  • 7. [Valproic acid in the treatment of epilepsy with special emphasis on serum level determination (author's transl)].
    Fröscher W, Schulz HU, Gugler R.
    Fortschr Neurol Psychiatr Grenzgeb; 1978 Jun 21; 46(6):327-41. PubMed ID: 352872
    [Abstract] [Full Text] [Related]

  • 8. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.
    Alvarez N, Besag F, Iivanainen M.
    J Intellect Disabil Res; 1998 Dec 21; 42 Suppl 1():1-15. PubMed ID: 10030426
    [Abstract] [Full Text] [Related]

  • 9. [Valproate sustained release in the treatment of epilepsy].
    Stefan H, Fraunberger B.
    Fortschr Neurol Psychiatr; 2005 Nov 21; 73(11):681-6. PubMed ID: 16283612
    [Abstract] [Full Text] [Related]

  • 10. [Sodium valproate and cognitive function].
    Bourgeois B.
    Praxis (Bern 1994); 1994 Oct 04; 83(40):1122-5. PubMed ID: 7939083
    [Abstract] [Full Text] [Related]

  • 11. [Therapeutic drug monitoring of valproate].
    Bentué-Ferrer D, Tribut O, Verdier MC, Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique.
    Therapie; 2010 Oct 04; 65(3):233-40. PubMed ID: 20699076
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics, drug interactions, and tolerability of valproate.
    DeVane CL.
    Psychopharmacol Bull; 2003 Oct 04; 37 Suppl 2():25-42. PubMed ID: 14624231
    [Abstract] [Full Text] [Related]

  • 13. [Sodium valproate (Na VPa) monotherapy in childhood epilepsy ].
    Dulac O, Steru D, Rey E, Arthuis M.
    Arch Fr Pediatr; 1982 Oct 04; 39(6):347-52. PubMed ID: 6812534
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Use of ethosuximide and valproate in the treatment of epilepsy.
    Wallace SJ.
    Neurol Clin; 1986 Aug 04; 4(3):601-16. PubMed ID: 3092003
    [Abstract] [Full Text] [Related]

  • 18. Conversion from delayed-release sodium valproate to extended-release sodium valproate: initial results and long-term follow-up.
    McCabe PH, Michel NC, McNew CD, Lehman EB.
    Epilepsy Behav; 2006 May 04; 8(3):601-5. PubMed ID: 16678766
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic concentration of antiepileptic drugs and the severity of epileptogenesis.
    Seino M, Kakegawa N.
    Electroencephalogr Clin Neurophysiol Suppl; 1982 May 04; 36():438-46. PubMed ID: 6819123
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy.
    Chou IJ, Lin KL, Wang HS, Wang CJ.
    Acta Paediatr Taiwan; 2007 May 04; 48(6):317-22. PubMed ID: 18437965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.